Jan ShultisNov 13 min readHope Biosciences Shares Promising Topline Results in Multiple SclerosisHope Biosciences, a clinical-stage biotechnology company today shares positive top-line results of a Phase II clinical trial.
Jan ShultisAug 84 min readOn Biotech and BerylAt Hope Biosciences, our love language is stewardship (cliché, perhaps, but true!). Some days that stewardship is grittier than others, like
Jan ShultisJul 33 min readSupporting a nimble biotechnology future, through NIIMBLHope Biosciences welcomes the workforce of the future